3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success Story - B&C-Gruppe

Institution: University of Natural Resources and Life Sciences, Vienna (BOKU), Department of Biotechnology Project lead: DI Miriam Klausberger, Ph.D., DI Mark Dürkop, Ph.D. Project description (German): Ein SARS-CoV-2-Antikörpertest gibt Auskunft darüber, ob jemand bereits mit dem Coronavirus infiziert war oder ob im Rahmen einer Impfung Antikörper gebildet wurden. Für den Antikörpernachweis nach einer Infektion oder […]

Controlled Human Infection Models To Accelerate Vaccine Development

COVID-19 Detection - Enzo Life Sciences

Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet

Therapeutic efficacy of monoclonal antibodies and antivirals against SARS- CoV-2 Omicron BA.1 in Syrian hamsters

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools by means of agent-based simulations calibrated to cluster tracing data

The territorial impact of COVID-19: Managing the crisis and recovery across levels of government

Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study - eBioMedicine

Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data

How a school holiday led to persistent COVID-19 outbreaks in Europe